Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 28 of 47

Results and Summary of Benefits: Atypical Antipsychotics for Bipolar Personality Disorder

Of seven studies of bipolar personality disorder (BPD), four showed statistically significant beneficial effects. Two studies showed some efficacy of aripiprazole, but the strength of evidence is low. One study showed that olanzapine is efficacious at 5–10 mg/day but not at 2.5 mg/day. The strength of evidence for the finding is low.

In summary, although there is some evidence for benefit from atypical antipsychotics for BPD, it is inadequate for a meta-analysis and conclusions about the statistical or clinical significance of the effect.